3Nickoloff BJ,Wrone-Smith T,Bonish B,et al. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158,
4Bata-Csorgo Z,Hammerberg C,Voorhees JJ,et al. Intralesional Tlymphocyte activation as a mediator of psoriatic epidermal hyperplasia. J Invest Dermatol, 1995, 105( 1 Suppl): 89S-94S.
5Soini Y,Kamel D, Paakko P, et al. Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions. Br J Dermatol, 1994, 131: 514-520.
6Moles JP,Theillet C, Basset-Seguin N, et al.Mutation of the tumor suppressor gene TP53 is not detected in psoriatic skin. J Invest Dermatol, 1993, 101: 100-102.
7Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease [ J ]. Circulation, 2011,123 (19) :2145-2156.
8Gudjonsson JE, Ding J, Li X, et al. Global gene expression anal- ysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin[ J]. J Invest Derma- tol, 2009,129(12) :2795-2804.
